9F Inc.

According to the Complaint, the Company made false and misleading statements to the market. 9F touted value and benefits to its financial institution partners and tri-party cooperation business model that did not exist. In fact, the Company and Property and Casualty Company Limited (“PICC”) were engaged in an ongoing dispute regarding payment of service fees. The Company’s collectability of service fees from PICC was at serious risk of non-payment. There was also a significant risk that PICC would discontinue credit insurance and guarantee protection to investors and institutional funding partners. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about 9F, investors suffered damages.

-->

CleanSpark, Inc.

According to the Complaint, the Company made false and misleading statements to the market. CleanSpark overstated multiple aspects of its business, including its customer list and contract details. The Company engaged in undisclosed related party transactions in multiple recent acquisitions. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about CleanSpark, investors suffered damages.

-->

Bit Digital, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Bit Digital overstated the size and capability of its bitcoin mining operation. Based on this fact, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Bit Digital, investors suffered damages.

-->

Walmart Inc.

According to the Complaint, the Company made false and misleading statements to the market. Walmart knowingly filled improper prescriptions written by “pill-mill” prescribers. Thousands of prescriptions filled by the Company demonstrated obvious red flags such as dangerous mixtures of medications. The Company’s management pressured its pharmacists to fill as many prescriptions as possible, making it difficult for them to comply with the law. The Company’s pharmacy revenues were artificially inflated due to filling invalid prescriptions in violation of the Controlled Substance Act dispensing requirements. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Walmart, investors suffered damages.

-->

GTT Communications, Inc.

According to the Complaint, the Company made false and misleading statements to the market. GTT failed to maintain proper internal controls related to the recording and reporting of  Cost of Telecommunications Services. The Company’s Cost of Telecommunications as previously reported included unsupported adjustments and were otherwise inaccurate. The Company’s failure to maintain internal controls resulted in a delay in the Company’s 10-Q quarterly reports. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about GTT, investors suffered damages.

-->

Tricida, Inc.

According to the Complaint, the Company made false and misleading statements to the market. Tricida’s NDA submission for veverimer was materially deficient as submitted to the FDA. The Company’s failure to produce a sufficient NDA for veverimer was likely to result in the FDA not accepting the application. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Tricida, investors suffered damages.

-->

QuantumScape Corporation

According to the Complaint, the Company made false and misleading statements to the market. QuantumScape dramatically overstated the purported success of its solid-state batteries, including their battery power, life, and energy density. The Company was unlikely to scale its battery technology to the multi-layer cells necessary to run electric vehicles. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about QuantumScape, investors suffered damages.

-->

ACM Research, Inc.

According to the Complaint, the Company made false and misleading statements to the market. ACM Research’s revenue and profits were diverted to related parties that remained undisclosed. As a result, the Company overstated its revenue and profits to investors. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about ACM Research, investors suffered damages.

-->

CD Projekt S.A.

According to the Complaint, the Company made false and misleading statements to the market. CD Projekt’s hotly-anticipated video game “Cyberpunk 2077” was essentially unplayable on current-generation Xbox and PlayStation consoles due to an overwhelming number of bugs and other problems. Sony, Microsoft, and the Company were forced to offer refunds to customers who bought “Cyberpunk 2077,” resulting in Sony removing the game from its PlayStation Store. The Company’s reputation was harmed significantly by the botched launch of “Cyberpunk 2077.” Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about CD Projekt, investors suffered damages.

-->

GoodRx Holdings, Inc.

According to the Complaint, the Company made false and misleading statements to the market. GoodRx timed its IPO so that it was priced before Amazon announced its competing service. This not only facilitated the IPO, but also created artificial demand to maximize the amount of money the Company and selling shareholders raised. The Company knew about Amazon’s competing service in advance of the IPO, making their statements in the Registration Statement about its competitive advantages to be false and misleading. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about GoodRx, investors suffered damages.

-->